Mostafa Ali

This independent retail pharmacy is a clean, stable, retail-only operation located in a healthy Pennsylvania market with no nearby independent competition. The pharmacy focuses exclusively on traditional retail dispensing, maintaining a strong generic mix and avoiding low-margin or problematic insurance plans. Ownership has intentionally kept the operation simple and compliant, creating a solid foundation with clear upside for a buyer who can implement consistent staffing or operational systems.OverviewBusiness Type: Independent Retail PharmacyModel: Retail onlyOwnership tenure: ~3 yearsOwnership structure: Two partnersOwner operatedFinancialsAnnual Revenue: ~$2.19MGross Margin: ~18%Revenue Mix:Brand Rx: ~$2.07MGenerics: ~$561K+Script Volume2024 Annual Scripts: ~29,063Employees & Staffing1 part-time pharmacist (~1 days/week)Current structure: Owners + part-time pharmacist coverageOperationsHours of Operation:Mon–Fri: 9:00 AM – ... Less

Business Overview• Independent retail pharmacy (~4 years established)• Sole owner-operator• Traditional retail structure• Recently passed Board inspection (no findings)• Clean compliance and tax standing• No outstanding debtBusiness Highlights• ~$950,000 annual revenue• ~$200,000 SDE• Immunization license in place• Lean, just-in-time inventory modelOverview• Business Type: Independent Retail Pharmacy• Ownership: Owner-OperatedOperations• No specialty focus• Immunizations not actively administered• Hours: Monday–Saturday, 9:00 AM – 1:00 PMStaffing• 1 Full-time Pharmacist (Owner)• 1 Pharmacy Technician (part-time)Lease Information• 5-year lease structure• First term concluding in September• 5-year renewal option availableReason for Sale• Owner relocating ... Less

Business OverviewEstablished in 2023, this retail pharmacy is a three-partnership ownership, with all partners being licensed pharmacists actively operating the business. The pharmacy accepts all major New Jersey insurance plans and is currently fully owner-operated with no additional employees.The operation is lean, clean, and turnkey — ideal for a pharmacist buyer or a small group looking to expand in New Jersey.Financials (2025)Annual Revenue: $550,000 – $600,000Net Income: 8% – 10%Total Revenue (Report Period): $364,583.99Total COGS: $330,441.47Total Gross Profit: ~$40,000Total Inventory: ~$28,294.72New Patients Added: 260Inventory (Seller Estimate): ~$25,000Financials Available: P&L and Tax ReturnsOperationsAccepts all NJ insurancesOwner-operated (no payroll expense)Primary wholesaler: KinrayRetail-focused modelClean accounting recordsSpace & LeaseSize: 1,400 sq ftLease Remaining: 10 yearsBusiness HighlightsRecently ... Less

OverviewExceptional opportunity to acquire a well-established independent retail pharmacy generating approximately $8.7 Million in annual revenue (2025) with strong prescription volume and stable third-party relationships.This pharmacy operates from a 4,200 sq. ft. freestanding building with a drive-thru window, dedicated parking lot, and in-house delivery system, making it a true community anchor.The real estate is owned by the seller and may be included in the transaction, offering buyers the opportunity to acquire both the operating business and the property.Financial Highlights (2025)Annual Revenue: ~$8,595,000~360 Scripts per Day~97,000 Scripts AnnuallyStrong Generic Dispensing Mix~95% Third-Party InsuranceAccepts All Major InsurancesNo Pending AuditsClean Compliance HistoryAdditional upside potential from upcoming program expansion.Operational HighlightsFull-service retail pharmacy modelBehavioral health prescriptions ... Less

Business OverviewConfidential, off-market specialty pharmacy platform headquartered in South Carolina. The company operates as a specialty-focused model with no retail or LTC exposure.Founded in 2022 by an experienced specialty pharmacy executive, the platform has scaled rapidly and maintains national infrastructure and multistate licensure.The business is structured for continued growth with strong payer relationships and established specialty programs.Financial Overview (High-Level)2025 Revenue: ~$19,000,0002024 TTM EBITDA: ~$600,0002025 Projected EBITDA: ~$1,000,000(Full financial package available upon NDA execution.)Key HighlightsLicensed in all 50 statesNational dual accreditationFully contracted with major insurersSpecialty-focused (no retail exposure)Strong contracts in South CarolinaNational shipping infrastructureVC-backed platformFounded by former $500M specialty executiveSeller open to equity rollover and ... Less

Business OverviewRare opportunity to acquire a long-standing independent retail pharmacy that has served its community for approximately 40 years. The business has demonstrated consistent performance and recent revenue growth while maintaining strong insurance relationships and regulatory compliance. The pharmacy operates from a highly visible shopping center location with favorable lease terms.Business HighlightsApproximately $7.1M revenue in 2025 (up from ~$6.48M in 2024)Established operation with 40-year history in same shopping centerApproximately 18 years in current unitAll major insurance contracts in placeNo pending regulatory or compliance issuesStrong, stable prescription volumeAttractive lease structureFinancial Summary2025 Revenue: ~$7,100,0002024 Revenue: ~$6,475,0002025 Payroll: ~$485,7252025 Net Profit: ~$313,6282025 Seller’s Discretionary Earnings (SDE): ~$476,449OperationsIndependent retail pharmacy ... Less